Instil Bio Management

Management criteria checks 4/4

Instil Bio's CEO is Bronson Crouch, appointed in Nov 2018, has a tenure of 6.17 years. total yearly compensation is $1.58M, comprised of 43.4% salary and 56.6% bonuses, including company stock and options. directly owns 1.94% of the company’s shares, worth $2.97M. The average tenure of the management team and the board of directors is 3.9 years and 4.6 years respectively.

Key information

Bronson Crouch

Chief executive officer

US$1.6m

Total compensation

CEO salary percentage43.4%
CEO tenure6.2yrs
CEO ownership1.9%
Management average tenure3.9yrs
Board average tenure4.6yrs

Recent management updates

Recent updates

Instil Bio appoints Tim Moore as COO

Sep 06

We're Keeping An Eye On Instil Bio's (NASDAQ:TIL) Cash Burn Rate

Jul 20
We're Keeping An Eye On Instil Bio's (NASDAQ:TIL) Cash Burn Rate

We're Hopeful That Instil Bio (NASDAQ:TIL) Will Use Its Cash Wisely

Jun 21
We're Hopeful That Instil Bio (NASDAQ:TIL) Will Use Its Cash Wisely

Instil Bio gains on FDA’s orphan drug designation for ITIL-168 in melanoma

Apr 27

CEO Compensation Analysis

How has Bronson Crouch's remuneration changed compared to Instil Bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$75m

Jun 30 2024n/an/a

-US$120m

Mar 31 2024n/an/a

-US$123m

Dec 31 2023US$2mUS$685k

-US$156m

Sep 30 2023n/an/a

-US$197m

Jun 30 2023n/an/a

-US$186m

Mar 31 2023n/an/a

-US$226m

Dec 31 2022US$5mUS$634k

-US$223m

Sep 30 2022n/an/a

-US$225m

Jun 30 2022n/an/a

-US$211m

Mar 31 2022n/an/a

-US$188m

Dec 31 2021US$36mUS$618k

-US$157m

Sep 30 2021n/an/a

-US$119m

Jun 30 2021n/an/a

-US$83m

Mar 31 2021n/an/a

-US$57m

Dec 31 2020US$6mUS$438k

-US$38m

Compensation vs Market: Bronson's total compensation ($USD1.58M) is about average for companies of similar size in the US market ($USD1.38M).

Compensation vs Earnings: Bronson's compensation has been consistent with company performance over the past year.


CEO

Bronson Crouch (51 yo)

6.2yrs

Tenure

US$1,577,289

Compensation

Mr. Bronson Crouch is the Chief Executive Officer and Chairman at Instil Bio, Inc. since November 2018. Mr. Crouch has served as Founding Partner of Curative Ventures Management LLC since January 2014. Mr....


Leadership Team

NamePositionTenureCompensationOwnership
Bronson Crouch
Chairman & CEO6.2yrsUS$1.58m1.94%
$ 3.0m
Sandeep Laumas
CFO & Chief Business Officer3.9yrsUS$922.92k0%
$ 0
Mark Dudley
Chief Scientific Officer3.3yrsno datano data

3.9yrs

Average Tenure

Experienced Management: TIL's management team is considered experienced (3.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Bronson Crouch
Chairman & CEO6.2yrsUS$1.58m1.94%
$ 3.0m
Neil Gibson
Lead Independent Non-Employee Director4.6yrsUS$82.65k0%
$ 0
Richard McGaughy
Independent Non-Employee Director4.6yrsUS$66.15k0%
$ 0
Gwendolyn Binder
Independent Non-Employee Director4.5yrsUS$57.15k0%
$ 0
George Matcham
Independent Non-Employee Director6.3yrsUS$57.15k0.58%
$ 890.4k

4.6yrs

Average Tenure

52yo

Average Age

Experienced Board: TIL's board of directors are considered experienced (4.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 03:24
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Instil Bio, Inc. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack AllenBaird
Mitchell KapoorH.C. Wainwright & Co.
Dingding ShiJefferies LLC